Short Interest in Autonomix Medical, Inc. (NASDAQ:AMIX) Drops By 62.1%

Autonomix Medical, Inc. (NASDAQ:AMIX) saw a significant decline in short interest in the month of December. As of December 15th, there was short interest totaling 133,864 shares, a decline of 62.1% from the November 30th total of 353,480 shares. Currently, 2.1% of the shares of the company are short sold. Based on an average daily volume of 221,552 shares, the days-to-cover ratio is currently 0.6 days. Based on an average daily volume of 221,552 shares, the days-to-cover ratio is currently 0.6 days. Currently, 2.1% of the shares of the company are short sold.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on AMIX. Zacks Research downgraded shares of Autonomix Medical from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 28th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Autonomix Medical in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Autonomix Medical presently has an average rating of “Hold” and an average price target of $5.00.

Autonomix Medical Stock Up 1.7%

NASDAQ AMIX opened at $0.61 on Friday. The stock has a market capitalization of $4.22 million, a P/E ratio of -0.13 and a beta of -2.87. Autonomix Medical has a 52-week low of $0.59 and a 52-week high of $4.58. The firm has a 50-day moving average price of $0.89 and a 200 day moving average price of $1.13.

Autonomix Medical (NASDAQ:AMIX) last released its earnings results on Wednesday, November 12th. The company reported ($1.38) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($1.38). On average, equities research analysts expect that Autonomix Medical will post -10 earnings per share for the current fiscal year.

Autonomix Medical Company Profile

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.